Prestige Consumer Healthcare (PBH) FY2020 results: revenue $963 million, down 1.3% on the year
Prestige Consumer Healthcare Inc. (PBH) reported revenue of $963 million for fiscal 2020, the year ended 31 March 2020, down 1.3% on the year before. Net income was $142 million, and diluted earnings per share $2.78. The figures are the company's own, from the 10-K it filed with the SEC on 8 May 2020.
Revenue
$963 million
-1.3% on the year
FY2013FY2020
Operating margin
30.2%
6.9% a year earlier
FY2013FY2020
Net income
$142 million
FY2013FY2020
Diluted EPS
$2.78
FY2013FY2020
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Revenue
963
976
1,041
-1.3%
Cost of revenue
411
420
465
-2.2%
Gross profit
552
556
577
-0.6%
Gross margin
57.3%
56.9%
55.4%
Operating income
291
67.5
216
+331.3%
Operating margin
30.2%
6.9%
20.7%
Interest expense
96.2
105
106
-8.4%
Pre-tax income
191
-38.1
107
Income tax
48.9
-2.3
-232
Effective tax rate
25.6%
n/a
-217.1%
Net income
142
-35.8
340
Net margin
14.8%
-3.7%
32.6%
Diluted EPS
$2.78
-$0.69
$6.34
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Operating cash flow
217
189
210
+14.7%
Capital expenditure
14.6
10.5
12.5
+38.9%
Free cash flow
203
179
198
+13.3%
Free cash flow margin
21.0%
18.3%
19.0%
Cash from investing
-16.6
55.4
-11.6
Cash from financing
-131
-249
-209
Depreciation and amortisation
29.0
31.8
33.4
-8.8%
Share-based compensation
7.6
7.4
8.9
+2.8%
Buybacks
56.7
50.0
0.0
+13.5%
Diluted shares, weighted
51m
52m
54m
-1.8%
Balance sheet
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Shareholders' equity
1,171
1,096
1,179
+6.9%
Debt
1,730
1,799
1,993
-3.8%
Operating lease liabilities
24.9
0.0
n/a
Finance lease liabilities
4.6
0.0
n/a
Other liabilities
583
547
589
+6.7%
Total liabilities and equity
3,514
3,441
3,761
+2.1%
Fixed assets
56.0
51.2
52.6
+9.4%
Goodwill
575
579
620
-0.6%
Intangible assets
2,479
2,507
2,781
-1.1%
Cash and equivalents
94.8
27.5
32.5
+244.2%
Receivables
151
149
141
+1.2%
Inventory
116
120
119
-3.2%
Other assets
42.0
7.9
15.1
+434.2%
Total assets
3,514
3,441
3,761
+2.1%
10-K for the year ended 31 March 2020, filed 8 May 2020: the filing.